The small intestine is sometimes metastasized by malignant melanoma. While small intestinal involvement is asymptomatic or usually nonspecific, intussusception causing intestinal obstruction is very rare. Herein we report the case of a 68-year-old man with small bowel intussusception due to metastatic malignant melanoma. Although he has been comprehensively treated with surgery, radiation, and immunotherapies, the disease rapidly progressed and consequently severe life-threatening intussusception developed on the small bowel. Because surgical resection of the obstructive melanoma lesions was successful, his quality of life was dramatically improved followed by the resumption of treatment with anti-PD-1. Several effective treatments for metastatic melanoma, including immune checkpoint inhibitors and targeted therapy, have been developed within the past decade. However, given the present case, surgical approaches to symptomatic metastatic melanoma lesions should still be considered as a treatment option for improving not only patients' critical condition but also their survival.
Introduction
The small intestine is sometimes metastasized by malignant melanoma [1] [2] [3] . Symptoms of small intestinal involvement are asymptomatic or usually nonspecific, like abdominal pain, nausea, and vomiting, which leads to a late diagnosis often made only after complications arise [4] [5] [6] . The most common complication is intestinal obstruction [6] , and intussusception causing intestinal How to cite this paper: Hanaoka, Y., Tanemura, A., Tanaka, M., Takafuji, M., Kiyohara, E., Wataya-Kaneda, M., Fujimoto, M. 
Case Presentation
A 68-year-old man had been affected by acral lentiginous melanoma (pT4b) on the right heel and received wide local resection of his primary lesion and a sentinel lymph node biopsy. Because one popliteal lymph node was positive for micro-metastasis, he subsequently underwent right popliteal lymph node dissection (one metastatic node out of four). Because lymph node metastasis was suspected during treatment with adjuvant interferon beta therapy, we performed right in- another mass in the proximal ileum (Figure 3(c) ). Small bowel resection was performed with end-to-end anastomosis (Figures 3(b)-(d) ). A histopathologic examination of the small bowel lesion confirmed metastatic melanoma ( Figure   3 (e) and Figure 3(f) ). The post-operative period was uneventful, and the patient was discharged on the 12 th postoperative day. After discharge, he was able to consume an oral diet, and immunotherapy with the anti PD-1 antibody nivolumab was resumed. He ultimately died 5 months after resection of the small bowel lesions and 44 months after surgery for the primary lesion.
Discussion
Intussusception results from the invagination of the proximal segment of the bowel into the lumen of a distal segment and is known to be associated with an lesions along with the neighboring bowel [8] . While intestinal and mesenteric metastases of malignant melanoma are usually disseminated and small, intussusception related to intraluminal masses of melanoma is quite uncommon [8] .
The usual time from the diagnosis of the primary tumor to that of metastases is usually within 2 -5 years [11] ; about 1.5% -4.4% of all patients with melanoma are diagnosed antemortem, while 50% -60% of patients with malignant melanoma present with metastases at an autopsy [1] .
While immune checkpoint inhibitors (anti PD-1 antibody and/or anti CTLA-4 antibody) have provided unprecedented gains in metastatic or advanced melanoma treatment [12] , the efficacy of immunotherapy on melanoma remains limited, and an increase in their anti-tumor efficacy is required urgently. Although the present case was comprehensively treated with surgery, radiation, and immunotherapies, the disease rapidly progressed, and severe intussusception of the small bowel was consequently detected by CT.
Because surgical resection of the obstructive melanoma lesions was successful, his quality of life was dramatically improved followed by the resumption of treatment with anti-PD-1. Several effective treatments for metastatic melanoma, including immune checkpoint inhibitors and targeted therapy, have been developed within the past decade [13] . However, given the present case, surgical approaches to symptomatic metastatic melanoma lesions should still be considered as a treatment option for improving not only patients' critical condition but also their survival.
Conclusion
The small intestine is sometimes metastasized by malignant melanoma while intussusception related to intraluminal masses of melanoma is quite uncommon.
Although the evolving role of immunotherapy and targeted therapy of metastatic malignant melanoma has been extended survival, surgical approaches to symptomatic metastatic melanoma lesions should still be considered as a treatment option for improving not only patients' critical condition but also their survival.
